- Home
- BIAF vs SINT Comparison
BIAF vs SINT Comparison
Compare BIAF & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- SINT
- Stock Information
- Founded
- BIAF 2014
- SINT 1996
- Country
- BIAF United States
- SINT United States
- Employees
- BIAF N/A
- SINT N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SINT Medical/Dental Instruments
- Sector
- BIAF Health Care
- SINT Health Care
- Exchange
- BIAF Nasdaq
- SINT Nasdaq
- Market Cap
- BIAF 13.0M
- SINT 11.6M
- IPO Year
- BIAF 2022
- SINT 2014
- Fundamental
- Price
- BIAF $2.49
- SINT $3.46
- Analyst Decision
- BIAF Hold
- SINT Strong Buy
- Analyst Count
- BIAF 1
- SINT 1
- Target Price
- BIAF N/A
- SINT $25.00
- AVG Volume (30 Days)
- BIAF 3.3M
- SINT 432.7K
- Earning Date
- BIAF 11-13-2025
- SINT 11-13-2025
- Dividend Yield
- BIAF N/A
- SINT N/A
- EPS Growth
- BIAF N/A
- SINT N/A
- EPS
- BIAF N/A
- SINT N/A
- Revenue
- BIAF $7,681,059.00
- SINT $1,861,000.00
- Revenue This Year
- BIAF N/A
- SINT N/A
- Revenue Next Year
- BIAF $20.04
- SINT $80.00
- P/E Ratio
- BIAF N/A
- SINT N/A
- Revenue Growth
- BIAF 4.99
- SINT N/A
- 52 Week Low
- BIAF $2.34
- SINT $1.71
- 52 Week High
- BIAF $46.53
- SINT $8.60
- Technical
- Relative Strength Index (RSI)
- BIAF 46.54
- SINT 42.21
- Support Level
- BIAF $2.43
- SINT $3.10
- Resistance Level
- BIAF $3.50
- SINT $3.82
- Average True Range (ATR)
- BIAF 0.29
- SINT 0.39
- MACD
- BIAF -0.09
- SINT -0.07
- Stochastic Oscillator
- BIAF 5.69
- SINT 25.03
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.